Tuberculosis (TB) Clinical Trials

14 recruiting

Tuberculosis (TB) Trials at a Glance

15 actively recruiting trials for tuberculosis (tb) are listed on ClinicalTrialsFinder across 6 cities in 14 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Bangkok Noi, Bangkok, and Bloemfontein. Lead sponsors running tuberculosis (tb) studies include Mahidol University, Chinese University of Hong Kong, and Bharat Biotech International Limited.

Browse tuberculosis (tb) trials by phase

Treatments under study

About Tuberculosis (TB) Clinical Trials

Looking for clinical trials for Tuberculosis (TB)? There are currently 14 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Tuberculosis (TB) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Tuberculosis (TB) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 115 of 15 trials

Recruiting
Phase 2

A Study to Evaluate the Efficacy, Safety and Immunogenicity of MTBVAC in Adolescents and Adults Living in a TB Endemic Region.

Tuberculosis (TB)
International AIDS Vaccine Initiative5,500 enrolled16 locationsNCT06272812
Recruiting
Phase 2

ATORvastatin in Pulmonary TUBerculosis: a POPulation PharmacoKinetics -PharmacoDynamics Sub-study (ATORTUB popPK-PD)

Pulmonary Tuberculosis (TB)
Obafemi Awolowo University Teaching Hospital80 enrolled3 locationsNCT07303699
Recruiting
Not Applicable

Effectiveness of Computer-Aided Detection Chest X-Ray Screening for Improving Tuberculosis Diagnostic Yield in Chinese Primary Health Care Settings: Study Protocol for a Prospective Cluster Randomized Controlled Trial

Tuberculosis (TB)
Xuelin Yang22,000 enrolled1 locationNCT06963606
Recruiting

Questioning the Epidemiology of Asymptomatic TB

TuberculosisHIV (Human Immunodeficiency Virus)HIV+1 more
Barcelona Institute for Global Health6,770 enrolled1 locationNCT07312266
Recruiting

Respiratory Health and Wellbeing Post Pulmonary Tuberculosis

Tuberculosis (TB)
Liverpool School of Tropical Medicine50 enrolled1 locationNCT07178860
Recruiting

ESAT6/CFP10 Skin Testing for TB Infection in Rheumatologic Patients

Tuberculosis (TB)
Chinese University of Hong Kong100 enrolled2 locationsNCT06796647
Recruiting
Not Applicable

Pharmacist-led Digital Interventions to Improve Tuberculosis Treatment Adherence

Tuberculosis (TB)
University of Malaya160 enrolled1 locationNCT07069387
Recruiting

PRecision biomArker-Guided MAnagement of TuberculosIs Contacts: a Discrete Choice Experiment

Tuberculosis (TB)
University College, London430 enrolled1 locationNCT07024836
Recruiting
Phase 2

Safety and Immunogenicity of a Mycobacterium Tuberculosis Vaccine MTBVAC in Healthy Indian Adults and Adolescents (BBV169/2024)

Tuberculosis (TB)
Bharat Biotech International Limited164 enrolled2 locationsNCT06997367
Recruiting
Not Applicable

A Confirmatory Trial of Adjunctive NAC to Prevent Post Tuberculosis Lung Disease

Tuberculosis (TB)
The Aurum Institute NPC242 enrolled1 locationNCT06909799
Recruiting
Not Applicable

Examining Psycho-Socioeconomic Linkages in TB Care: The UPLIFT Trial

Tuberculosis (TB)
Freundeskreis Für Internationale Tuberkulosehilfe e.V1,324 enrolled12 locationsNCT06916962
Recruiting

Patients With Tuberculosis, Mycobacteriosis or Latent Tuberculosis

Tuberculosis (TB)Mycobacterial Infection
IRCCS Azienda Ospedaliero-Universitaria di Bologna13,000 enrolled1 locationNCT06764576
Recruiting
Not Applicable

Research on Key Interventional Technologies for Controlling the Epidemic in High-prevalence Areas of Tuberculosis in Guangxi, China

Tuberculosis (TB)
University of Toronto72,000 enrolled1 locationNCT06702774
Recruiting

Evaluation of IGRA, Symptoms and Chest Radiograph for Subclinical TB Detection in ESRD and KT

Tuberculosis (TB)
Mahidol University160 enrolled1 locationNCT06700876
Recruiting
Phase 4

Gene-guided N-acetyl Cysteine for Prophylaxis of Anti-tuberculous Drug- Induced Hepatitis

N-AcetylcysteineTuberculosis (TB)Isoniazid Toxicity+6 more
Mahidol University116 enrolled1 locationNCT06484530